Total Payments
$1.1M
2024 Payments
$79,977
Companies
35
Transactions
1,709
Medicare Patients
12,008
Medicare Billing
$3.4M
Payment Breakdown by Category
Other$803,657 (74.2%)
Travel$206,459 (19.1%)
Food & Beverage$37,153 (3.4%)
Consulting$34,997 (3.2%)
Education$943.30 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $712,087 | 394 | 65.7% |
| Travel and Lodging | $206,459 | 315 | 19.1% |
| Honoraria | $91,570 | 48 | 8.5% |
| Food and Beverage | $37,153 | 902 | 3.4% |
| Consulting Fee | $34,997 | 16 | 3.2% |
| Education | $943.30 | 34 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $285,202 | 354 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $206,445 | 278 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $188,270 | 213 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $127,390 | 108 | $0 (2024) |
| Relypsa, Inc. | $113,967 | 233 | $0 (2020) |
| Vifor Pharma, Inc. | $55,661 | 75 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $35,729 | 66 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $32,480 | 51 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $18,130 | 84 | $0 (2024) |
| Ardelyx, Inc. | $5,718 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $79,977 | 166 | Bayer Healthcare Pharmaceuticals Inc. ($18,291) |
| 2023 | $84,541 | 147 | Fresenius USA Marketing, Inc. ($32,159) |
| 2022 | $132,687 | 164 | Bayer HealthCare Pharmaceuticals Inc. ($60,558) |
| 2021 | $116,546 | 162 | Bayer HealthCare Pharmaceuticals Inc. ($38,250) |
| 2020 | $89,099 | 173 | Otsuka America Pharmaceutical, Inc. ($22,762) |
| 2019 | $256,438 | 368 | Otsuka America Pharmaceutical, Inc. ($65,584) |
| 2018 | $139,813 | 245 | Amgen Inc. ($59,845) |
| 2017 | $184,108 | 284 | Amgen Inc. ($102,564) |
All Payment Transactions
1,709 individual payment records from CMS Open Payments — Page 1 of 69
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,614.00 | General |
| Category: Cardio-renal | ||||||
| 12/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: DIABETES | ||||||
| 12/09/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Honoraria | Cash or cash equivalent | $950.00 | General |
| Category: Nephrology | ||||||
| 12/09/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $33.56 | General |
| Category: Inflammation | ||||||
| 12/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Travel and Lodging | In-kind items and services | $919.75 | General |
| Category: Cardio-renal | ||||||
| 12/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardio-renal | ||||||
| 12/05/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: NEPHROLOGY | ||||||
| 12/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,614.00 | General |
| Category: Cardio-renal | ||||||
| 12/03/2024 | Ardelyx, Inc. | XPHOZAH 30 MG (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: NEPHROLOGY | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $25.85 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/28/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Nephrology | ||||||
| 11/27/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Education | In-kind items and services | $99.99 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $26.17 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,314.00 | General |
| Category: Cardio-renal | ||||||
| 11/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Travel and Lodging | In-kind items and services | $919.75 | General |
| Category: Cardio-renal | ||||||
| 11/22/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $38.49 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,614.00 | General |
| Category: Cardio-renal | ||||||
| 11/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $41.14 | General |
| Category: Cardio-renal | ||||||
| 11/21/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: Hyperkalemia | ||||||
| 11/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: Cardio-renal | ||||||
| 11/19/2024 | Ardelyx, Inc. | XPHOZAH 30 MG (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: NEPHROLOGY | ||||||
| 11/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Travel and Lodging | In-kind items and services | $990.50 | General |
| Category: Cardio-renal | ||||||
| 11/14/2024 | Ardelyx, Inc. | XPHOZAH 30 MG (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: NEPHROLOGY | ||||||
| 11/14/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $123.63 | General |
| Category: Cardio-renal | ||||||
| 11/14/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: LUPUS NEPHRITIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 3,364 | 10,044 | $1.9M | $808,839 |
| 2022 | 22 | 3,108 | 10,279 | $2.3M | $830,224 |
| 2021 | 22 | 2,799 | 9,941 | $2.5M | $954,547 |
| 2020 | 23 | 2,737 | 47,392 | $2.4M | $840,874 |
Total Patients
12,008
Total Services
77,656
Medicare Billing
$3.4M
Procedure Codes
90
All Medicare Procedures & Services
90 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 143 | 809 | $404,400 | $192,312 | 47.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 339 | 1,585 | $226,493 | $100,694 | 44.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 283 | 955 | $183,202 | $91,512 | 50.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 545 | 888 | $201,920 | $85,811 | 42.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 353 | 514 | $175,995 | $70,340 | 40.0% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 78 | 155 | $93,000 | $44,383 | 47.7% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2023 | 104 | 259 | $103,600 | $42,589 | 41.1% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 19 | 163 | $75,775 | $38,507 | 50.8% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 214 | 613 | $70,495 | $25,925 | 36.8% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 214 | 611 | $61,100 | $24,544 | 40.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 74 | 141 | $62,582 | $23,767 | 38.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 125 | 125 | $48,000 | $21,054 | 43.9% |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2023 | 26 | 1,937 | $58,110 | $11,124 | 19.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 372 | 514 | $24,277 | $9,197 | 37.9% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 77 | 136 | $17,363 | $7,803 | 44.9% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 23 | 23 | $5,942 | $3,402 | 57.3% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 207 | 210 | $8,400 | $3,398 | 40.5% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 18 | 39 | $5,626 | $3,387 | 60.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 26 | 240 | $12,000 | $2,732 | 22.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 19 | $4,221 | $2,004 | 47.5% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 57 | 59 | $5,010 | $1,914 | 38.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 22 | $3,430 | $1,359 | 39.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 27 | 27 | $2,675 | $1,080 | 40.4% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 163 | 866 | $432,900 | $208,749 | 48.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 396 | 1,878 | $375,536 | $109,011 | 29.0% |
About Dr. Rodolfo Batarse, M.D
Dr. Rodolfo Batarse, M.D is a Internal Medicine healthcare provider based in Rancho Mirage, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417914193.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rodolfo Batarse, M.D has received a total of $1.1M in payments from pharmaceutical and medical device companies, with $79,977 received in 2024. These payments were reported across 1,709 transactions from 35 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($712,087).
As a Medicare-enrolled provider, Batarse has provided services to 12,008 Medicare beneficiaries, totaling 77,656 services with total Medicare billing of $3.4M. Data is available for 4 years (2020–2023), covering 90 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Nephrology
- Location Rancho Mirage, CA
- Active Since 04/27/2006
- Last Updated 11/09/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1417914193
Products in Payments
- Velphoro (Drug) $201,829
- Parsabiv (Biological) $176,171
- JYNARQUE (Drug) $153,778
- Veltassa (Drug) $139,769
- Kerendia (Drug) $125,725
- ACTHAR (Biological) $68,148
- Parsabiv (Drug) $56,280
- SAMSCA (Drug) $34,674
- Sensipar (Drug) $27,798
- FARXIGA (Drug) $17,183
- XPHOZAH 30 MG (Drug) $5,500
- KORSUVA (Drug) $4,593
- INVOKANA (Drug) $3,570
- Vafseo (Drug) $2,347
- Korsuva (Drug) $2,326
- KRYSTEXXA (Biological) $2,185
- EPOGEN (Biological) $2,026
- TARPEYO (Drug) $1,466
- FERAHEME (Drug) $936.65
- LOKELMA (Drug) $822.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Rancho Mirage
Dr. Evangelos Diamantakos, D.o, D.O
Internal Medicine — Payments: $125,909
Internal Medicine $125,909
Suzanne Chaves, Md, MD
Internal Medicine — Payments: $25,547
Internal Medicine $25,547
David Ko, Md, MD
Internal Medicine — Payments: $16,454
Internal Medicine $16,454
Meng Zhao, Md, MD
Internal Medicine — Payments: $10,067
Internal Medicine $10,067
Dr. Tyler Davis, M.d, M.D
Internal Medicine — Payments: $9,078
Internal Medicine $9,078
Dr. Arun Chakrabarty, M.d, M.D
Internal Medicine — Payments: $6,995
Internal Medicine $6,995